Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/16/2010US20100317735 High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica
12/16/2010US20100317729 New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317710 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
12/16/2010US20100317706 HNF4alpha MODULATORS AND METHODS OF USE
12/16/2010US20100317690 Treatment of protein folding disorders
12/16/2010US20100317679 Substituted aryl-fused spirocyclic amines
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317676 Fused heterocyclic compounds, and compositions and uses thereof
12/16/2010US20100317653 Oxadiazole derivatives as dgat inhibitors
12/16/2010US20100317651 Pyrazinooxazepine derivatives
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010US20100317645 Substituted diazepine sulfonamides as bombesin receptor subtype-1 modulators
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317642 Pharmaceutical composition of orlistat
12/16/2010US20100317635 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/16/2010US20100317622 Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317602 Nutritive compositions and methods of using same
12/16/2010US20100317601 Casein Derived Peptides And Uses Thereof
12/16/2010US20100317576 Methods of enhancing diabetes resolution
12/16/2010US20100317575 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative
12/16/2010US20100317574 Diketopiperazine Microparticles with Defined Isomer Contents
12/16/2010US20100317573 Pediatric fiber mixture
12/16/2010US20100317571 Methods for reducing cd36 expression
12/16/2010US20100317570 Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor
12/16/2010US20100317562 Dietary Compositions
12/16/2010US20100316753 Formulations and methods for reducing abdominal fat and waist circumference
12/16/2010US20100316750 Cholesterol lowering supplement
12/16/2010US20100316745 Use of a cereal extract as a slimming active agent in a slimming cosmetic composition
12/16/2010US20100316744 Plant sprout-based emulsions, process for preparing them and use thereof
12/16/2010US20100316743 INHIBITION OF THE FORMATION OF AGEs
12/16/2010US20100316736 Appetite suppressant
12/16/2010US20100316727 Treatment of inflammatory disorders with ozone
12/16/2010US20100316708 Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316692 Product and method for reducing substance craving
12/16/2010US20100316691 Biodegradable intravaginal medical device for delivery of therapeutics
12/16/2010US20100316680 Anti-inflammatory properties of marine lipid compositions
12/16/2010US20100316679 Compositions for treating or preventing obesity and insulin resistance disorders
12/16/2010US20100316644 Truncated actriib-fc fusion proteins
12/16/2010US20100316589 Coated Pharmaceutical Compositions
12/16/2010US20100316575 Modulating body weight
12/16/2010CA2765329A1 Oil composition, formulations comprising the oil composition, and the use thereof to reduce accumulation of visceral fat, improve glucose tolerance, and prevent or treat obesity related diseases and disorders
12/16/2010CA2765156A1 Diketopiperazine microparticles with defined isomer contents
12/16/2010CA2765075A1 Egfr and par2 regulation of intestinal permeability
12/16/2010CA2764890A1 Methods for increasing thermogenic adipocytes
12/16/2010CA2764808A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010CA2764797A1 Melanocortin receptor-specific peptides
12/16/2010CA2764571A1 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
12/16/2010CA2764385A1 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
12/16/2010CA2764105A1 Growth hormone polypeptides and methods of making and using same
12/16/2010CA2762619A1 Novel cyclopentane derivatives
12/15/2010EP2261333A2 Pharmaceutical composition comprising anti-miRNA antisense oligonucleotides
12/15/2010EP2261250A1 Albumin fusion proteins
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261213A1 Heterocyclic compound
12/15/2010EP2261210A1 3-substituted sulfonyl piperazine derivative
12/15/2010EP2261203A1 Phenylcyclobutylamide derivatives and their stereoisomers, the preparing processes and the uses thereof
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260855A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same
12/15/2010EP2260842A2 Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass
12/15/2010EP2260051A1 Glucopyranoside derivatives
12/15/2010EP2260038A1 Purine derivatives as a3 receptor- selective agonists
12/15/2010EP2260017A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
12/15/2010EP2259790A1 Abca-1 elevating compounds and the use thereof
12/15/2010EP2259787A2 Ikki inhibitor therapies and screening methods, and related ikki diagnostics
12/15/2010EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
12/15/2010EP1926720B1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
12/15/2010EP1914232B1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivatives
12/15/2010EP1838172B1 Novel nutraceutical compositions
12/15/2010EP1771424B1 Novel 2,4-diaminothiazol-5-one derivatives
12/15/2010EP1748774B1 Compositions comprising flavonoids and tocotrienols and uses thereof
12/15/2010EP1715865B9 Hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid
12/15/2010EP1680112B1 N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1534667B1 Muscarinic agonists
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
12/15/2010EP1196050B2 Compositions for providing and maintaining energy and mental alertness
12/15/2010EP1053001B1 Novel mixed amylin activity compounds
12/15/2010CN1965696B Health tea capable of lowering blood sugar
12/15/2010CN1907394B Medicine for treating diabetes foot
12/15/2010CN1802386B GLP-1 analog fusion proteins
12/15/2010CN101918423A Organic compounds
12/15/2010CN101918402A Octahydroquinoli zines for antidiabetic treatment
12/15/2010CN101918384A Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
12/15/2010CN101918376A 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors
12/15/2010CN101918371A Amide derivatives as sirtuin modulators
12/15/2010CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
12/15/2010CN101918363A Phenyl acetamide derivative
12/15/2010CN101918009A Composition for improving liver metabolism and diagnostic method
12/15/2010CN101917999A Modulation of protein trafficking
12/15/2010CN101914591A Application of candida tropicalis to preparation of xylitol and application of high-purity xylitol product to pharmacy and health care
12/15/2010CN101914168A Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof
12/15/2010CN101914164A Application of polysaccharide from mulberry leaves in preventing and treating diabetes
1 ... 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 ... 1298